Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy.
Michmerhuizen NL, Owen JH, Heft Neal ME, Mann JE, Leonard E, Wang J, Zhai J, Jiang H, McHugh JB, Brenner JC, Prince MEP.
Michmerhuizen NL, et al. Among authors: zhai j.
J Neurooncol. 2020 Mar;147(1):25-35. doi: 10.1007/s11060-020-03418-7. Epub 2020 Feb 17.
J Neurooncol. 2020.
PMID: 32067197
Free PMC article.